Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210). - Ferreras C; Hernández-Blanco C; Martín-Quirós A; Al-Akioui-Sanz K; Mora-Rillo M; Ibáñez F; Díaz-Almirón M; Cano-Ochando J; Lozano-Ojalvo D; Jiménez-González M; Goterris R; Sánchez-Zapardiel E; et al. (Cytotherapy, 2024)